EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microbial diversity in drug-naïve Parkinson’s disease patients

Eliša Papić, Valentino Rački, Mario Hero iD, Ana Nyasha Zimani, Mojca Čižek Sajko iD, Gloria Rožmarić iD, Nada Starčević Čizmarević, Saša Ostojić, Miljenko Kapović, Goran Hauser, Aleš Maver, Borut Peterlin und 2 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0328761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Eliša Papić und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Rijeka grant, Croatian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a neurological disorder characterized by rigidity, bradykinesia and tremor. Several genetic and environmental causes of PD are known, and there is emerging evidence of the possible contribution of the gut microbiome to the disease onset, severity, and response to therapy. While previous research has shown several differences in the microbiome of PD patients under therapy as opposed to healthy controls, few prospective studies have included drug-naïve patients. In order to evaluate the gut microbiome composition prior to therapy initiation, we collected and performed 16S rRNA gene sequencing of the stool samples from 49 drug-naïve PD patients and compared them to 34 diet and lifestyle-matched controls from the Croatian population (GiOPARK Project). While no significant alpha diversity difference was observed between the patients and controls, the differential relative abundance analysis showed an increase in Bacteroides fluxus , B. interstinalis , B. eggerthii , and Dielma fastidiosa in the drug-naïve PD patients compared to controls, while Alistipes , Barnesiella and Dialister spp . were decreased in patients compared to controls. Despite preserved overall diversity, these changes may indicate early microbial dysbiosis and represent a foundation for future studies exploring microbiome changes across disease progression and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGastrointestinal MicrobiomeHumansMaleFemaleAgedMiddle AgedRNA, Ribosomal, 16SFecesCase-Control StudiesDysbiosisBacteria

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
  • Clinic of Neurology, Clinical Hospital Center Rijeka, Rijeka, Croatia.
  • Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Slovenia.
  • Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
  • Department of Internal Medicine, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
  • Clinical Hospital Center Rijeka, Rijeka, Croatia.

ORCID-Profile: Mario Hero, Mojca Čižek Sajko, Gloria Rožmarić, Anja Kovanda, Vladimira Vuletić

Förderung

  • University of Rijeka grant
  • Croatian Science Foundation

Zitieren

APA

Papić, E., Rački, V., Hero, M., Zimani, A. N., Čižek Sajko, M., Rožmarić, G., Starčević Čizmarević, N., Ostojić, S., Kapović, M., Hauser, G., Maver, A., Peterlin, B., Kovanda, A., & Vuletić, V. (2025). Microbial diversity in drug-naïve Parkinson’s disease patients. PLOS One. https://doi.org/10.1371/journal.pone.0328761

Vancouver

Papić E, Rački V, Hero M, Zimani AN, Čižek Sajko M, Rožmarić G, et al. Microbial diversity in drug-naïve Parkinson’s disease patients. PLOS One. 2025. doi:10.1371/journal.pone.0328761

BibTeX
@article{Papi2025,
  author = {Papić, Eliša and Rački, Valentino and Hero, Mario and Zimani, Ana Nyasha and Čižek Sajko, Mojca and Rožmarić, Gloria and Starčević Čizmarević, Nada and Ostojić, Saša and Kapović, Miljenko and Hauser, Goran and Maver, Aleš and Peterlin, Borut and Kovanda, Anja and Vuletić, Vladimira},
  title = {Microbial diversity in drug-naïve Parkinson’s disease patients},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0328761}
}
Kostenlos starten →